Although CSAD ranked second in variable importance within the AMRS model (Figure 3e), PSAT1 (the highest-ranked gene) has been studied and validated for its prognostic and immunotherapeutic roles in ccRCC (50), whereas the biological functions of CSAD remain poorly characterized. This evidence concerns the gene CSAD and nonpapillary renal cell carcinoma.